The long-term administration of non-steroidal anti-inflammatory drugs reduces the risk of AD by inhibiting the expression of COX-2-mediated reciprocal management of IL-1β and Aβ between glial cells and neurons [32,33]. Here, PTGS2 is linked to Alzheimer disease.